Designed multiple ligands. An emerging drug discovery paradigm

被引：1086

作者：

Morphy, R ^{[1
]}

Rankovic, Z ^{[1
]}

机构：

[1] Organon Labs, Med Chem Dept, Newhouse ML1 5SH, Lanark, Scotland

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 21期

关键词：

D O I：

10.1021/jm058225d

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：6523 / 6543

页数：21

共 105 条

[1] Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine [J].

Aslanian, R ;

Mutahi, MW ;

Shih, NY ;

Piwinski, JJ ;

West, R ;

Williams, SM ;

She, S ;

Wu, RL ;

Hey, JA .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (12) :1959-1961

[2] 3,4-dihydro-2H-benzoxazinones are 5-HT1A receptor antagonists with potent 5-HT reuptake inhibitory activity [J].

Atkinson, PJ ;

Bromidge, SM ;

Duxon, MS ;

Gaster, LM ;

Hadley, MS ;

Hammond, B ;

Johnson, CN ;

Middlemiss, DN ;

North, SE ;

Price, GW ;

Rami, HK ;

Riley, GJ ;

Scott, CM ;

Shaw, TE ;

Starr, KR ;

Stemp, G ;

Thewlis, KM ;

Thomas, DR ;

Thompson, M ;

Vong, AKK ;

Watson, JM .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) :737-741

[3] Bicyclo[2.2-1]heptanes as novel triple re-uptake inhibitors for the treatment of depression [J].

Axford, L ;

Boot, JR ;

Hotten, TM ;

Keenan, M ;

Martin, FM ;

Milutinovic, S ;

Moore, NA ;

O'Neill, MF ;

Pullar, IA ;

Tupper, DF ;

Van Belle, KR ;

Vivien, V .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) :3277-3280

[4] Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor [J].

Barbey, S ;

Goossens, L ;

Taverne, T ;

Cornet, J ;

Choesmel, V ;

Rouaud, C ;

Gimeno, G ;

Yannic-Arnoult, S ;

Michaux, C ;

Charlier, C ;

Houssin, R ;

Hénichart, JP .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (05) :779-782

[5] Dual D2-receptor and β2-adrenoceptor agonists for the treatment of airway diseases.: 1.: Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues [J].

Bonnert, RV ;

Brown, RC ;

Chapman, D ;

Cheshire, DR ;

Dixon, J ;

Ince, F ;

Kinchin, EC ;

Lyons, AJ ;

Davis, AM ;

Hallam, C ;

Harper, ST ;

Unitt, JF ;

Dougall, IG ;

Jackson, DM ;

McKechnie, K ;

Young, A ;

Simpson, WT .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (25) :4915-4917

[6] 7-alkoxy-4-phenylamino-3-quinolinecarbonitriles as dual inhibitors of Src and Abl kinases [J].

Boschelli, DH ;

Wang, YND ;

Johnson, S ;

Wu, BQ ;

Ye, F ;

Sosa, ACB ;

Golas, JM ;

Boschelli, F .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1599-1601

[7] (R)-(+)-N-[3-[5-[(4-FLUOROPHENYL)METHYL]-2-THIENYL]-1-METHYL-2-PROPYNYL]-N-HYDROXYUREA (ABT-761), A 2ND-GENERATION 5-LIPOXYGENASE INHIBITOR [J].

BROOKS, CDW ;

STEWART, AO ;

BASHA, A ;

BHATIA, P ;

RATAJCZYK, JD ;

MARTIN, JG ;

CRAIG, RA ;

KOLASA, T ;

BOUSKA, JB ;

LANNI, C ;

HARRIS, RR ;

MALO, PE ;

CARTER, GW ;

BELL, RL .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (24) :4768-4775

[8] Design and synthesis of a novel synthetic NAPAP-pentasaccharide conjugate displaying a dual antithrombotic action [J].

Buijsman, RC ;

Basten, JEM ;

van Dinther, TG ;

van der Marel, GA ;

van Boeckel, CAA ;

van Boom, JH .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) :2013-2018

[9] Identification and chemical synthesis of MDL 105,212, a non-peptide tachykinin antagonist with high affinity for NK1 and NK2 receptors. [J].

Burkholder, TP ;

Kudlacz, EM ;

Le, TB ;

Knippenberg, RW ;

Shatzer, SA ;

Maynard, GD ;

Webster, ME ;

Horgan, SW .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (08) :951-956

[10] Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake [J].

Bymaster, FP ;

Beedle, EE ;

Findlay, J ;

Gallagher, PT ;

Krushinski, JH ;

Mitchell, S ;

Robertson, DW ;

Thompson, DC ;

Wallace, L ;

Wong, DT .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (24) :4477-4480

← 1 2 3 4 5 6 7 8 9 10 →